Published on: June 10, 2025 |
By: WealthMintr Team
YSG has gapped up by 2.8% today on a volume of 1.5 million shares. This positive market reaction is driven by the announcement of positive Phase 2 clinical trial results for its lead drug candidate, increasing institutional investment, and broader positive sentiment within the biotechnology sector. Table of Contents Reasons for the Gap Up....
Continue Reading